glp-1 patent expiration The Heavy Price of Drugs – I-MAK HIMS to Introduce Generic GLP-1
Description
However, clinicians must be vigilant for specific rare adverse events
Never go barefoot
There is also a risk of regaining lost weight
Medicaid coverage of GLP-1s varies, with several states planning to restrict coverage amid the drugs high costs and recent cuts in federal health care spending
4 Concluding remarks, place in therapy, and future perspective Tirzepatide is a novel agent that is approved for the treatment of type 2 diabetes and will likely be approved for weight loss
